News
Dr. Reddy's Laboratories Ltd. closed 8.38% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...
Citi believes that market expectations for the GLP-1 opportunity in Canada may be too optimistic, based on its latest deep ...
Dr. Reddy's Laboratories Ltd. 500124 shares slid 1.47% to 1,321.20 Indian rupees Thursday, on what proved to be an all-around ...
Dr. Reddy's Laboratories, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1326.4.The stock has experienced fluctuations today ...
Shares of Dr Reddy's Laboratories decreased by 2 per cent to Rs 1,317 in morning trading, following Citi Research's decision ...
1d
NDTV Profit on MSNDr. Reddy's Shares Decline After Citi Reduces Target Price Amid Growth ConcernsCiti expressed caution on the growth outlook, particularly around the Canadian GLP-1 market and the highly anticipated launch ...
The scrip traded higher than the 5-day, 10-, 20-, 30-, 50-, 100-, 150-day and 200-day simple moving averages (SMAs).
Ahmedabad: Intas Pharma has announced the appointment of Rambabu Ogirala as Associate Vice President - Manufacturing ...
Alvotech and Dr. Reddy’s have entered into a collaboration and license agreement to co-develop, manufacture and commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results